US Broker Ratings

Elevance Health, Inc. (ELV) Stock Analysis: A Potential 80% Upside for Investors

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans sector, stands at a pivotal juncture that may intrigue savvy investors. With a market capitalization of $62.39 billion,..

Royalty Pharma plc (RPRX) Stock Analysis: A Unique Biotech Play with 16.67% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector not just for its unique business model but also for its promising financial outlook. As a leading player in..

Amgen Inc. (AMGN) Stock Analysis: A Closer Look at Its 6.62% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture the attention of investors with its expansive portfolio of human therapeutics and a robust market capitalization of..

Novartis AG (NVS) Stock Analysis: Navigating a 12.4% Revenue Growth in the Healthcare Sector

Novartis AG (NYSE: NVS), a titan in the healthcare sector, continues to demonstrate its prowess in the drug manufacturing industry with a significant market cap of $222.48 billion. Headquartered in..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating Growth Potential with a 7.93% Upside

Cardinal Health, Inc. (NYSE: CAH) continues to stand as a formidable entity in the healthcare sector, focusing on medical distribution and extending its reach across the United States and internationally...

Waters Corporation (WAT) Stock Analysis: A Healthcare Powerhouse with a 35% Upside Potential

Waters Corporation (NYSE: WAT), a key player in the Healthcare sector, stands out in the Diagnostics & Research industry due to its innovative analytical workflow solutions. Headquartered in Milford, Massachusetts,..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Giant with a 2.55% Upside Potential

ResMed Inc. (NYSE: RMD) stands as a prominent entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $37.82 billion, ResMed has..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Veeva Systems Inc. (NYSE: VEEV), a prominent player in the healthcare sector, is making significant strides in the health information services industry. Headquartered in Pleasanton, California, Veeva provides innovative cloud-based..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Evaluating Growth Potential and Strong Buy Ratings

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, continues to capture investor attention with its innovative approach to developing therapeutics based on ribonucleic acid interference (RNAi). With..

Stryker Corporation (SYK) Stock Analysis: Strong Revenue Growth and Analyst Confidence Signal Upside Potential

Stryker Corporation (SYK), a leading player in the healthcare sector, stands out in the medical devices industry with a substantial market capitalization of $148.82 billion. As a U.S.-based company, Stryker..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Healthcare Titan with a 10.97% Upside Potential

Intuitive Surgical, Inc. (ISRG), a leader in the healthcare sector focusing on medical instruments and supplies, stands as a beacon of innovation with its cutting-edge robotic surgical systems. Headquartered in..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a 7.37% Upside Potential Amid Healthcare Growth

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the U.S. medical care facilities industry, boasting an impressive market capitalization of $86.88 billion. Headquartered in Nashville, Tennessee, HCA..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 31% Potential Upside in the Animal Health Sector

As Zoetis Inc. (NYSE: ZTS) continues to command attention in the healthcare sector, individual investors are keen to understand what makes this animal health giant an enticing option. With a..

Danaher Corporation (DHR) Stock Analysis: Exploring a 30% Potential Upside with Strong Buy Ratings

As an industry leader in healthcare diagnostics and research, Danaher Corporation (NYSE: DHR) presents a compelling opportunity for investors seeking growth in the healthcare sector. With a robust market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering a 34.73% Potential Upside in the Healthcare Sector

Novo Nordisk A/S (NYSE: NVO), a prominent player in the healthcare sector, has been capturing investor attention with its robust performance metrics and strategic growth initiatives. Based in Bagsvaerd, Denmark,..

AbbVie Inc. (ABBV) Stock Analysis: Navigating a 10.5% Potential Upside Amid Robust Dividend Yield

AbbVie Inc. (NYSE: ABBV), a formidable player in the healthcare sector, has piqued the interest of investors with its compelling financial metrics and diverse product portfolio. With a market capitalization..

Autolus Therapeutics plc (AUTL)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: 502 Bad Gateway 502 Bad Gateway clou (truncated…)

..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Exploring a 37.97% Potential Upside for Biotechnology Investors

Verve Therapeutics, Inc. (NASDAQ: VERV), an innovative player in the biotechnology sector, has been capturing the attention of investors with its promising gene-editing technologies aimed at revolutionizing cardiovascular disease treatment...

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring the 135.85% Upside Potential

Rapport Therapeutics, Inc. (RAPP) has emerged as a beacon of innovation in the biotechnology sector, particularly focusing on the development of small molecule medicines targeting central nervous system (CNS) disorders...

AngioDynamics, Inc. (ANGO) Stock Analysis: Potential 79.25% Upside with Strategic Growth in Medical Devices

AngioDynamics, Inc. (NASDAQ: ANGO) has recently caught the attention of investors with a compelling 79.25% potential upside, as indicated by the average target price from analysts. Operating in the healthcare..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds